Marks Successful Inaugural Fulfillment for French Pilot Prog - Initial fulfillment satisfies obligation as primary provider of dried medical cannabis
- Premium, medical cannabis products sourced from the company's EU GMP facility in Denmark
EDMONTON, AB, Aug. 25, 2021 /PRNewswire/ - Aurora Germany GmbH, a subsidiary of Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, and Ethypharm, have successfully delivered their initial shipment of cannabis to the French medical cannabis pilot program, set to begin serving patients in the coming weeks. Aurora and Ethypharm were selected by the National Agency for the Safety of Medicines and Health Products (ANSM) to supply the entire medical cannabis dried flower range (three lots of the tender) to French patients during the pilot program.
https://www.prnewswire.com/news-releases/aurora-cannabis-marks-successful-inaugural-fulfillment-for-french-pilot-program-301362265.html